Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Atripla
Pharma
Gilead moves ahead with $247M settlement in HIV antitrust case
The preliminary settlement deal comes after Gilead and Teva, a generics giant, prevailed in a high-stakes jury trial this summer.
Eric Sagonowsky
Sep 26, 2023 10:39am
Gilead can't escape antitrust suit centered on Cipla deal
Aug 23, 2022 1:44pm
Gilead lets community take the lead with $3M grant
Feb 15, 2021 10:17am
SCOTUS rebuffs Gilead, Merck appeals in high-profile battles
Jan 8, 2019 10:30am
DOJ moves to kill its Gilead false claims case
Dec 3, 2018 11:55am
Express Scripts bars 48 drugs for 2019, hitting AbbVie, Gilead
Aug 7, 2018 12:29pm
